IDEXX Laboratories, Inc. (IDXX)
NASDAQ · Healthcare
IDEXX Laboratories, Inc. Operating Income 2008–2025
IDEXX Laboratories, Inc. annual/quarterly operating income history and growth rate from 2008 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- IDEXX Laboratories, Inc. operating income for the quarter ending March 31, 2026 was 362.6 M, a 14.55% increase year-over-year.
- IDEXX Laboratories, Inc. operating income for the twelve months ending March 31, 2026 was 1.4 B, a 23.21% increase year-over-year.
- IDEXX Laboratories, Inc. annual operating income for 2025 was 1.4 B, a 20.53% increase from 2024.
- IDEXX Laboratories, Inc. annual operating income for 2024 was 1.1 B, a 2.84% increase from 2023.
- IDEXX Laboratories, Inc. annual operating income for 2023 was 1.1 B, a 22.07% increase from 2022.
- IDEXX Laboratories, Inc. annual operating income for 2022 was 898.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
IDEXX Laboratories, Inc. Operating Income — FAQ
IDEXX Laboratories, Inc. (IDXX) operating income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is IDEXX Laboratories, Inc.'s operating income?
IDEXX Laboratories, Inc. (IDXX) reported operating income of $1.36B for fiscal 2025.
Where can I see IDXX's operating income history?
The chart and table above show IDEXX Laboratories, Inc.'s operating income by year and by quarter, including the growth rate.